Bioceres Crop Solutions Corp (BIOX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Bioceres Crop Solutions Corp stock (BIOX) is currently trading at $0.41. Bioceres Crop Solutions Corp PS ratio (Price-to-Sales) is 0.07. Analyst consensus price target for BIOX is $2.00. WallStSmart rates BIOX as Underperform.
- BIOX PE ratio analysis and historical PE chart
- BIOX PS ratio (Price-to-Sales) history and trend
- BIOX intrinsic value — DCF, Graham Number, EPV models
- BIOX stock price prediction 2025 2026 2027 2028 2029 2030
- BIOX fair value vs current price
- BIOX insider transactions and insider buying
- Is BIOX undervalued or overvalued?
- Bioceres Crop Solutions Corp financial analysis — revenue, earnings, cash flow
- BIOX Piotroski F-Score and Altman Z-Score
- BIOX analyst price target and Smart Rating
Bioceres Crop Solutions Corp
📊 No data available
Try selecting a different time range
Smart Analysis
Bioceres Crop Solutions Corp (BIOX) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, eps growth. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.
Bioceres Crop Solutions Corp (BIOX) Key Strengths (3)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
Earnings per share surging 34.40% year-over-year
Supporting Valuation Data
Bioceres Crop Solutions Corp (BIOX) Areas to Watch (7)
Company is destroying shareholder value
Revenue declining -16.40%, a shrinking business
Company is losing money with a negative profit margin
Very thin margins with limited operational efficiency
Micro-cap company with very limited liquidity and high volatility
Growth is fairly priced, not cheap, not expensive
Moderate institutional interest at 31.71%
Bioceres Crop Solutions Corp (BIOX) Detailed Analysis Report
Overall Assessment
This company scores 50/100 in our Smart Analysis, earning a D+ grade. Out of 10 metrics analyzed, 3 register as strengths (avg 10.0/10) while 7 fall into concern territory (avg 2.4/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book, EPS Growth. Valuation metrics including Price/Sales (0.07), Price/Book (0.32) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 34.40%.
The Bear Case
The primary concerns are Return on Equity, Revenue Growth, Profit Margin. Some valuation metrics including PEG Ratio (1.95) suggest expensive pricing. Growth concerns include Revenue Growth at -16.40%, which may limit upside. Profitability pressure is visible in Return on Equity at -19.00%, Operating Margin at 8.92%, Profit Margin at -17.70%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -19.00% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -16.40% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Price/Sales, Price/Book) and negatives (Return on Equity, Revenue Growth). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
BIOX Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
BIOX's Price-to-Sales ratio of 0.07x trades 26% below its historical average of 0.1x (0th percentile). The current valuation is 33% below its historical high of 0.11x set in Feb 2026, and 6% above its historical low of 0.07x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~0.1x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Bioceres Crop Solutions Corp (BIOX) · BASIC MATERIALS › AGRICULTURAL INPUTS
The Big Picture
Bioceres Crop Solutions Corp is in a turnaround phase, with management focused on restoring profitability. Revenue reached 318M with 16% decline year-over-year. The company is currently unprofitable, posting a -17.7% profit margin.
Key Findings
Generating 17M in free cash flow and 17M in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 16% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -17.7% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Sector dynamics: monitor AGRICULTURAL INPUTS industry trends, competitive moves, and regulatory changes that could impact Bioceres Crop Solutions Corp.
Bottom Line
Bioceres Crop Solutions Corp is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Bioceres Crop Solutions Corp(BIOX)
NASDAQ
BASIC MATERIALS
AGRICULTURAL INPUTS
USA
Bioceres Crop Solutions Corp.